Johnson & Johnson posted weaker-than-expected quarterly revenue on Tuesday as sales of prescription drugs and cardiac stents disappointed, sending its shares down more than 2 percent.
*For more on this story,
read the full Reuters
article.
J & J; Profit Beats Estimates, Sales Fall Short
Want more from the best local business newspaper in the country?
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
Would you like to subscribe to Orange County Business Journal?
One-Year for Only $99
- Weekly in-depth coverage in print and digital formats
- Special Features: OC's Wealthiest, Top Priced Home Sales, Giving Guide, OC500, Charity Event Guide, Best Places to Work, Indispensables, Largest Charitable Gifts
- The annual Book of Lists: Orange County's top companies across every industry
